Table 4.

Effect of clinicopathological features on XAGE1 gene expression in cancer patients.

XAGE1 gene expression
Tumor group	Mean±SE of XAGE1 gene
Benign tumors	0.254±0.06
Malignant tumors	10.89±0.77
LSD Value (P-value)	2.319 **(0.0001]
** (P≤0.01).
Age groups	Mean±SE of XAGE1 gene
children aged 0–14 years	0.0178±0.0115
Teenagers and young adults aged 15–24 years	0.00595±0.0022
Adults aged 25–49 years	0.8447±0.267
Adults aged 50–74 years	19.34±2.17
LSD Value (P-value)	1.762 **(0.0001)
** (P≤0.01)
Histological tumor type	Mean±SE of XAGE1 gene
Mucinous	49.44±4.52
Serous	0.7252±0.284
Endometrioid	0.0566±0.032
Germ cell tumor	0.0178±0.84
Burner tumor	0.0134±0.0094
Clear cell	0.00229±0.0016
LSD Value (P-value)	3.821 **(00001)
** (P≤0.01)
Tumor stage	Mean±SE of XAGE1 gene
Stage 1	0.01717±0.0085
Stage 3	57.06±3.06
LSD Value (P-value)	1.948 **(0.0001)
** (P≤0.01).